Cawthron sells wine testing lab to Hill in 'multi-million dollar deal'

Hill Laboratories, specialists in agricultural, environmental and food testing, has agreed to buy the Cawthron Institute’s Marlborough wine testing laboratory in what is described as a “multi-million dollar deal.”

The Cawthron Institute, researchers of coastal and freshwater systems, will transfer the operation of its Marlborough lab to Hill Laboratories in June following due diligence, it said in a statement. Nelson-based Cawthron’s environmental chemistry testing programme is also included in the sale. No price was disclosed.

“It is a pretty significant multi-million dollar deal,” said Martin Lovell a spokesperson for Hill Laboratories told BusinessDesk. “The Marlborough lab has about five to six people in it – it is predominately a wine lab which is one of the reasons we are interested in it.”

Hill Laboratories recently opened a new wine lab in Christchurch, launching its Vine to Vintage wine testing service.

The Marlborough lab is already export testing certified and fits well with our plans to expand further into the wine market, Hill said in a statement.

(BusinessDesk)

BusinessDesk.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Govt support for NZME/Stuff merger difficult, not impossible, says Jarden
NZ dollar stalled; US-China trade signals remain mixed
Ryman warns NZ, Australia to take population ageing more seriously
MARKET CLOSE: NZ shares fall as US-China trade concerns weigh on markets; Ryman slips
NZ dollar stalled; US-China trade deal may be postponed
AFT Pharmaceuticals starts to hit its straps
Crown seeks US$100m from Tui operator; Prospector moving on
Pacific Edge goes back to shareholders for another $20m
Crown seeks $100m from Tui operator Tamarind
Ryman underlying annual profit may rise by up to 17%